Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
16-Bromo-6β-methoxy-3,5-cycloandrost-16-en-17-yl]-pyridine is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.